192 related articles for article (PubMed ID: 32253242)
1. Apolipoprotein E Triggers Complement Activation in Joint Synovial Fluid of Rheumatoid Arthritis Patients by Binding C1q.
Vogt LM; Kwasniewicz E; Talens S; Scavenius C; Bielecka E; Ekdahl KN; Enghild JJ; Mörgelin M; Saxne T; Potempa J; Blom AM
J Immunol; 2020 May; 204(10):2779-2790. PubMed ID: 32253242
[TBL] [Abstract][Full Text] [Related]
2. Activation of Complement by Pigment Epithelium-Derived Factor in Rheumatoid Arthritis.
Vogt LM; Talens S; Kwasniewicz E; Scavenius C; Struglics A; Enghild JJ; Saxne T; Blom AM
J Immunol; 2017 Aug; 199(3):1113-1121. PubMed ID: 28637898
[TBL] [Abstract][Full Text] [Related]
3. Native, amyloid fibrils and beta-oligomers of the C-terminal domain of human prion protein display differential activation of complement and bind C1q, factor H and C4b-binding protein directly.
Sjöberg AP; Nyström S; Hammarström P; Blom AM
Mol Immunol; 2008 Jun; 45(11):3213-21. PubMed ID: 18406463
[TBL] [Abstract][Full Text] [Related]
4. Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals.
Biró E; Nieuwland R; Tak PP; Pronk LM; Schaap MC; Sturk A; Hack CE
Ann Rheum Dis; 2007 Aug; 66(8):1085-92. PubMed ID: 17261534
[TBL] [Abstract][Full Text] [Related]
5. Carbamylation reduces the capacity of IgG for hexamerization and complement activation.
Lubbers R; Oostindie SC; Dijkstra DJ; Parren PWHI; Verheul MK; Abendstein L; Sharp TH; de Ru A; Janssen GMC; van Veelen PA; van den Bremer ETJ; Bleijlevens B; de Kreuk BJ; Beurskens FJ; Trouw LA
Clin Exp Immunol; 2020 Apr; 200(1):1-11. PubMed ID: 31853959
[TBL] [Abstract][Full Text] [Related]
6. Interactions of complement proteins C1q and factor H with lipid A and Escherichia coli: further evidence that factor H regulates the classical complement pathway.
Tan LA; Yang AC; Kishore U; Sim RB
Protein Cell; 2011 Apr; 2(4):320-32. PubMed ID: 21574022
[TBL] [Abstract][Full Text] [Related]
7. Complement inhibitor C4b-binding protein interacts directly with small glycoproteins of the extracellular matrix.
Happonen KE; Sjöberg AP; Mörgelin M; Heinegård D; Blom AM
J Immunol; 2009 Feb; 182(3):1518-25. PubMed ID: 19155499
[TBL] [Abstract][Full Text] [Related]
8. Interaction between fibronectin and C1q in rheumatoid synovial fluid and normal plasma.
Carsons SE; Schwartzman S; Diamond HS; Berkowitz E
Clin Exp Immunol; 1988 Apr; 72(1):37-42. PubMed ID: 3135129
[TBL] [Abstract][Full Text] [Related]
9. Contribution of chondroitin sulfate A to the binding of complement proteins to activated platelets.
Hamad OA; Nilsson PH; Lasaosa M; Ricklin D; Lambris JD; Nilsson B; Ekdahl KN
PLoS One; 2010 Sep; 5(9):e12889. PubMed ID: 20886107
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of C1q binding to antigen-antibody complexes by a factor in rheumatoid arthritis serum.
Niven IP; Whaley K
Rheumatol Int; 1986; 6(5):205-8. PubMed ID: 3492025
[TBL] [Abstract][Full Text] [Related]
11. C1q-bearing immune complexes detected by a monoclonal antibody to human C1q in rheumatoid arthritis sera and synovial fluids.
Antes U; Heinz HP; Schultz D; Brackertz D; Loos M
Rheumatol Int; 1991; 10(6):245-50. PubMed ID: 2041983
[TBL] [Abstract][Full Text] [Related]
12. Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis.
Brodeur JP; Ruddy S; Schwartz LB; Moxley G
Arthritis Rheum; 1991 Dec; 34(12):1531-7. PubMed ID: 1747138
[TBL] [Abstract][Full Text] [Related]
13. Studies on the interactions between C-reactive protein and complement proteins.
Bíró A; Rovó Z; Papp D; Cervenak L; Varga L; Füst G; Thielens NM; Arlaud GJ; Prohászka Z
Immunology; 2007 May; 121(1):40-50. PubMed ID: 17244159
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of classical complement pathway activation in rheumatoid arthritis: measurement of C1q-C4 complexes as novel activation products.
Wouters D; Voskuyl AE; Molenaar ET; Dijkmans BA; Hack CE
Arthritis Rheum; 2006 Apr; 54(4):1143-50. PubMed ID: 16572449
[TBL] [Abstract][Full Text] [Related]
15. Complement activation by phospholipids: the interplay of factor H and C1q.
Tan LA; Yu B; Sim FC; Kishore U; Sim RB
Protein Cell; 2010 Nov; 1(11):1033-49. PubMed ID: 21153520
[TBL] [Abstract][Full Text] [Related]
16. Complement activation in seropositive and seronegative rheumatoid arthritis. 125I-C1q binding capacity and complement breakdown products in serum and synovial fluid.
Lambert PH; Nydegger UE; Perrin LH; McCormic J; Fehr K; Miescher PA
Rheumatology; 1975; 6():52-9. PubMed ID: 1202608
[TBL] [Abstract][Full Text] [Related]
17. High molecular weight non-immunoglobulin salivary agglutinins (NIA) bind C1Q globular heads and have the potential to activate the first complement component.
Boackle RJ; Connor MH; Vesely J
Mol Immunol; 1993 Feb; 30(3):309-19. PubMed ID: 8433709
[TBL] [Abstract][Full Text] [Related]
18. The collagen-like component of the complement system, C1q, is recognized by 7 S autoantibodies and is functionally impaired in synovial fluids of patients with rheumatoid arthritis.
Trinder PK; Maeurer MJ; Brackertz D; Loos M
Immunology; 1996 Mar; 87(3):355-61. PubMed ID: 8778019
[TBL] [Abstract][Full Text] [Related]
19. Binding of Streptococcus pneumoniae endopeptidase O (PepO) to complement component C1q modulates the complement attack and promotes host cell adherence.
Agarwal V; Sroka M; Fulde M; Bergmann S; Riesbeck K; Blom AM
J Biol Chem; 2014 May; 289(22):15833-44. PubMed ID: 24739385
[TBL] [Abstract][Full Text] [Related]
20. The C1q binding activity of IgG is modified in vitro by reactive oxygen species: implications for rheumatoid arthritis.
Griffiths HR; Lunec J
FEBS Lett; 1996 Jun; 388(2-3):161-4. PubMed ID: 8690077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
